This invention relates to novel aromatic heterocyclic carboxylic acid amide derivatives of formula (I) that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive to the modulation of potassium channels.
[EN] NOVEL AROMATIC HETEROCYCLIC CARBOXYLIC ACID AMIDE DERIVATIVES USEFUL AS POTASSIUM CHANNEL MODULATORS<br/>[FR] NOUVEAUX DÉRIVÉS AMIDES D'ACIDE CARBOXYLIQUE AROMATIQUE HÉTÉROCYCLIQUE UTILES COMME MODULATEURS DU CANAL POTASSIUM
申请人:NEUROSEARCH AS
公开号:WO2008138917A1
公开(公告)日:2008-11-20
[EN] This invention relates to novel aromatic heterocyclic carboxylic acid amide derivatives of formula (I) that are found to be potent modulators of potassium channels and, as such, are valuable candidates for the treatment of diseases or disorders as diverse as those which are responsive to the modulation of potassium channels. [FR] La présente invention concerne de nouveaux dérivés amides d'acide carboxylique aromatique hétérocyclique de formule (I) qui se sont avérés de puissants modulateurs des canaux potassium et en tant que tels, sont des candidats appréciables pour le traitement de maladies ou de troubles aussi divers que ceux qui répondent à la modulation des canaux potassium.
A series of novel 1,2,3,5-tetrahydroimidazo[2,1-b]quinazolin-2-one derivatives substituted with a secondary amino group has been prepared and tested for the activities of inhibitingplateletaggregation in rats in vitro and ex vivo. Most of the compounds were found to be the potentinhibitors of plateletaggregation. Some of the active compounds were soluble in water and effective via iv infusion in